April 11, 2023
A group of pharmaceutical companies has accused Takeda Pharmaceuticals and several other drug manufacturers of entering into anti-competitive deals related to the gout drug Colcrys, launching the second federal lawsuit in Pennsylvania that claims the deals were meant to postpone the development of a generic market for the drug.